Mitok Bio

Mitok Bio

觅投克生物

Mitok Bio

Biotech/Healthcare

Mitouke Biotech develops stem cell therapies for age-related diseases in companion animals. It primarily develops mesenchymal stem cell (MSC) therapies for elderly cats and dogs, targeting indications including muscle atrophy, inflammatory bowel disease, and osteoarthritis.

Latest round: Pre Series A (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-04-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.